结论肺移植是目前治疗终末期间质性肺病的唯一有效手段。
Conclusion lung transplantation is the only effective treatment for end-stage interstitial lung disease.
接受特罗凯治疗的患者中观察到罕见的严重的间质性肺病(ILD)疑似事件，甚至导致死亡。
Infrequent cases of serious Interstitial Lung Disease (ILD) -like events, including fatalities, have been observed in patients receiving Tarceva.
结论气道中心性间质纤维化不同于其他间质性肺病，但其是否为一个独特的疾病有待进一步明确。
Objective To describe a form of interstitial lung disease pathologically characterized by small airway-centered interstitial fibrosis(ACIF).
结论气道中心性间质纤维化不同于其他间质性肺病，但其是否为一个独特的疾病有待进一步明确。
Objective To describe a form of interstitial lung disease pathologically characterized by small airway-centered interstitial fibrosis(ACIF).
应用推荐